Intractable epilepsy

Lancet

Volumn 353, Issue 9160, 1999, Pages 1238-

  Shuper, Avinoam ^a   Gutman, Aliza ^b   Mimouni, Marc ^a  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE REPORT; CHILD; DIET THERAPY; HUMAN; INTRACTABLE EPILEPSY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SEIZURE;

EID: 0344507108     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)11444-7     Document Type: Article

References (5)

1. Hirose S, Mitsudome A, Yasumoto S, et al. Valporate therapy does not deplete carnitine levels in otherwise healthy children. Pediatrics 1998; 101: E9.
2. Stanley CA. Carnitine disorders. Adv Pediatr 1995; 42: 209-42.
3. Marks WA, Morris MP, Bodensteiner JB, et al. Gastritis with valporate therapy. Arch Neurol 1988; 45: 903-05.
4. Weaver LT, Rosenthal SR, Galdstone W, et al. Carnitine deficiency: a possible cause of gastrointestinal dysmotility. Acta Paediatr 1992; 81: 79-81.
5. Tein I, Dimauro S, Xie ZW, Devivo DC. Heterozygotes for plasmalemmal carnitine transporter defect are at increased risk for valproic acid-associated impairment of carnitine uptake in cultured human skin fibroblasts. J Inher Metab Dis 1995; 18: 313-22.